AGP Picks
View all

The best science and technology news from the Middle East

Provided by AGP

Middle East Tech Today
Got News to Share?
Got News to Share? globe Explore more publications!

Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 21, 2026

Lonseal Announces the Launch of Lonsky Metalluxe, a New Aviation Flooring Collection
May 21, 2026

Lonseal Announces the Launch of Lonsky Metalluxe, a New Aviation Flooring Collection

Indeterminate EIN Presswire
Andreessen Horowitz Joins SPARQ's $8.5M Seed Round as AI-Native Game Engine Launches from Innovation City Ras Al Khaimah
May 21, 2026

Andreessen Horowitz Joins SPARQ's $8.5M Seed Round as AI-Native Game Engine Launches from Innovation City Ras Al Khaimah

Indeterminate EIN Presswire
UAE AI Firm Publishes Governance Framework Guide as Businesses Navigate Overlapping Federal and Free Zone AI Regulations
May 21, 2026

UAE AI Firm Publishes Governance Framework Guide as Businesses Navigate Overlapping Federal and Free Zone AI Regulations

Indeterminate EIN Presswire
The First Ever Luxury Rehab in the Himalayas - Veda Rehabilitation and Wellness launches Veda Rehab in Sikkim
May 21, 2026

The First Ever Luxury Rehab in the Himalayas - Veda Rehabilitation and Wellness launches Veda Rehab in Sikkim

Indeterminate EIN Presswire
VVC Exploration Corporation Provides Regulatory Update and Clarifies a Previous Incorrect Statement about CYRB
May 21, 2026

VVC Exploration Corporation Provides Regulatory Update and Clarifies a Previous Incorrect Statement about CYRB

Indeterminate GlobeNewswire
Audiencerate: Riccardo Fabbri wird Chief Technology Officer. Die KI-gesteuerte Phase der Plattformen für KMU und Medienagenturen beginnt
May 21, 2026

Audiencerate: Riccardo Fabbri wird Chief Technology Officer. Die KI-gesteuerte Phase der Plattformen für KMU und Medienagenturen beginnt

Indeterminate GlobeNewswire
Audiencerate : Riccardo Fabbri rejoint l’équipe en tant que directeur technique. Début de la phase pilotée par l’IA des plateformes pour PME et agences médias
May 21, 2026

Audiencerate : Riccardo Fabbri rejoint l’équipe en tant que directeur technique. Début de la phase pilotée par l’IA des plateformes pour PME et agences médias

Indeterminate GlobeNewswire
Midland Exploration Completes a $5.3 Million Private Placement
May 21, 2026

Midland Exploration Completes a $5.3 Million Private Placement

Indeterminate GlobeNewswire
Exploration Midland complète un placement privé de 5,3 millions $
May 21, 2026

Exploration Midland complète un placement privé de 5,3 millions $

Indeterminate GlobeNewswire
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
May 21, 2026

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 21, 2026

Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease

Indeterminate GlobeNewswire
Samba TV Launches Project Gravity, an Independent Data Activation Platform for the Agentic Era
May 21, 2026

Samba TV Launches Project Gravity, an Independent Data Activation Platform for the Agentic Era

Indeterminate GlobeNewswire
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 21, 2026

Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease

Indeterminate GlobeNewswire
Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma
May 21, 2026

Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma

Indeterminate GlobeNewswire
Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026
May 21, 2026

Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026

Indeterminate GlobeNewswire
Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
May 21, 2026

Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

Indeterminate GlobeNewswire
Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026

Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Indeterminate GlobeNewswire
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
May 21, 2026

Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors

Indeterminate GlobeNewswire
Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering
May 21, 2026

Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering

Indeterminate GlobeNewswire
Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
May 21, 2026

Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
LinkedIn Facebook

Sign up for:

Middle East Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.